Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Hammes LS, Branca M, Grunjberga V, Erzen M, Sarian LO, Juschenko A, Costa S, Podistov J, Syrjänen S; New Independent States of the Former Soviet Union and the Latin American Screening Study Research Groups. Syrjänen K, et al. Among authors: costa s. Int J Gynecol Cancer. 2009 Jul;19(5):934-42. doi: 10.1111/IGC.0b013e3181a834fe. Int J Gynecol Cancer. 2009. PMID: 19574788
Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Costa S, Syrjänen K. Syrjänen S, et al. Among authors: costa s. Am J Clin Pathol. 2009 Dec;132(6):883-92. doi: 10.1309/AJCPQQ07WUTZUTES. Am J Clin Pathol. 2009. PMID: 19926580
Up-regulation of 14-3-3sigma (Stratifin) is associated with high-grade CIN and high-risk human papillomavirus (HPV) at baseline but does not predict outcomes of HR-HPV infections or incident CIN in the LAMS study.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Costa S, Syrjänen K. Syrjänen S, et al. Among authors: costa s. Am J Clin Pathol. 2010 Feb;133(2):232-40. doi: 10.1309/AJCP49DOITYDCTQJ. Am J Clin Pathol. 2010. PMID: 20093232
p300 expression is related to high-risk human papillomavirus infections and severity of cervical intraepithelial neoplasia but not to viral or disease outcomes in a longitudinal setting.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Arlindo F, Sakamoto-Maeda M, Costa S, Syrjänen K. Syrjänen S, et al. Among authors: costa s. Int J Gynecol Pathol. 2010 Mar;29(2):135-45. doi: 10.1097/PGP.0b013e3181bccaec. Int J Gynecol Pathol. 2010. PMID: 20173499
Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Tatti S, Branca M, Erzen M, Hammes LS, Costa S, Longatto-Filho A, Syrjänen K. Syrjänen S, et al. Among authors: costa s. Am J Clin Pathol. 2010 Jul;134(1):50-9. doi: 10.1309/AJCP90IKJNQLSNRB. Am J Clin Pathol. 2010. PMID: 20551266
Competing-risks regression models in analysis of biomarkers as predictors of high-risk human papillomavirus (HPV) infection outcomes and incident CIN in the LAMS cohort.
Syrjänen S, Longhato-Filho A, Sarian LO, Naud P, Derchain S, Rottelli-Martins C, Tatti S, Branca M, Eržen M, Hammes LS, Matos J, Gontijo R, Bragança J, Arlindo FC, Maeda MY, Costa S, Syrjänen K. Syrjänen S, et al. Among authors: costa s. Int J Gynecol Pathol. 2013 Jul;32(4):406-15. doi: 10.1097/PGP.0b013e31826739b1. Int J Gynecol Pathol. 2013. PMID: 23722514 Clinical Trial.
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group. Branca M, et al. Among authors: costa s. Int J Gynecol Pathol. 2008 Apr;27(2):265-73. doi: 10.1097/PGP.0b013e318159cbc0. Int J Gynecol Pathol. 2008. PMID: 18317213
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Costa S, Benedetto A, Casolati EA, Favalli C, Paba P, Di Bonito P, Mariani L, Syrjänen S, Bonifacio D, Accardi L, Zanconati F, Syrjänen K; HPV-Pathogen ISS Study Group. Branca M, et al. Among authors: costa s. Am J Clin Pathol. 2005 Jul;124(1):113-21. doi: 10.1309/L8BWF431WU9AC8FJ. Am J Clin Pathol. 2005. PMID: 15923164
3,541 results